Macrogenics, Inc. · NASDAQ:MGNX
BB Biotech AG reported a 15.80% stake in Macrogenics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
BB Biotech AG reported a 15.80% stake in Macrogenics, Inc., 9,929,963 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 15.80%
- Shares
- 9,929,963
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BB Biotech AG | 15.80% | 9,929,963 |
| Biotech Target N.V. | 15.80% | 9,929,963 |
Source
Related
- Macrogenics, Inc.
- BB Biotech AG
- Macrogenics, Inc. shareholders
- Schedule 13G/A · BB Biotech AG · Jun 13, 2025
- Form 4 · Bonvini Ezio · Oct 7, 2026
- Form 4 · Peters Jeffrey Stuart · Aug 20, 2026
- Form 4 · Bonvini Ezio · Aug 18, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Bank of America Corp · Aug 3, 2026